Join this exclusive tour of Cicada Health Tech Hub and get a sneak peek of Westmead's newest innovation hub.

The Cicada Health Tech Hub will act as a unique home for early-stage med, bio and health tech startups and teams providing affordable office space, commercialisation activation programs, and a landing pad for industry-seeking solutions to their research and business challenges.

Meet the team:
Sally-Ann Williams - CEO of Cicada Innovations
Sian Priest - Director Community & Communications - Cicada Innovations
Lilly Bojarski - General Manager - Cicada Innovations Health Tech Hub
Dr Katja Beitat - Head of Health Tech Programs - Cicada Innovations
Zvezde Klingenberg - Programs Manager - Cicada Innovations Health Tech Hub
Prashanth Rajan - Investment Analyst from Brandon Capital

Opening address from Investment NSW Head of Innovation and Entrepreneurship - Liza Noonan

Tour the Facilities!

Get a chance to view the cutting-edge facilities designed to foster collaboration, creativity, and breakthroughs. Peek into the spaces where the next big ideas in health tech are taking shape.

Event Agenda:
4:30 - 5:15 pm Registration, Networking, and Tour of Health Tech Hub Incubator Space
5:15 - 5:30 pm Welcome to Country and Opening Remarks
5:30 - 6:00 pm Panel Discussion
6:00 - 7:30 pm Networking and Social Mixer

After the tour, there will be a chance to network, exchange ideas, share your insights, and build connections with like-minded innovators.

Find out more about the Cicada Health Tech Hub

The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.